MedTrace Logo

Quality of Life and Visual Acuity of Visglyc Eye Drops on Dry Eye Patients

NCT04063644 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-03-23

No results posted yet for this study

Summary

Clinical trial with medical devices, post-authorization, parallel, single-blind, randomized, comparative, prospective to study how afects the quality of life the use of ocular eye drops on patients with dry eye symptomatology and age-related loss of visual acuity.

Secondary purposes: efects on the dry eye symptomatology, efect on visual acuity and treatment adherence.

Conditions

  • Dry Eye Syndromes
  • Cataract

Interventions

DEVICE

Vis Glyc Neo

1 drop in each eye, three times a day.

DEVICE

Physiological saline solution

1 drop in each eye, three times a day.

Sponsors & Collaborators

  • OPKO Health, Inc.

    lead INDUSTRY

Principal Investigators

  • Beatriz Sarmiento Torres, MD, MSc · Hospital Universitario 12 Octubre

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-30
Primary Completion
2020-12-22
Completion
2020-12-22

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04063644 on ClinicalTrials.gov